As of March 2025 Protalix BioTherapeutics has a market cap of NZ$0.28 Billion. This makes Protalix BioTherapeutics the world's 8478th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
On Mar 13th, 2025 the market cap of Protalix BioTherapeutics was reported to be: